These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11422597)

  • 21. Why drug prices will go lower.
    Tully S
    Fortune; 1993 May; 127(9):56-8, 60, 62 passim. PubMed ID: 10125261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perspectives. Drug formularies pose legal threat to providers.
    Moskowitz DB
    Faulkner Grays Med Health; 1995 Feb; 49(6):suppl 1-4. PubMed ID: 10139750
    [No Abstract]   [Full Text] [Related]  

  • 23. The response to health care reform by the pharmaceutical industry.
    Krulwich AS
    Food Drug Law J; 1995; 50(1):1-22. PubMed ID: 10342983
    [No Abstract]   [Full Text] [Related]  

  • 24. Public policy considerations in the pricing of prescription drugs in the United States.
    Rucker TD
    Int J Health Serv; 1974; 4(1):171-9. PubMed ID: 4829895
    [No Abstract]   [Full Text] [Related]  

  • 25. In that case: a pharmaceutical company that makes generic versions of commonly used drugs has produced a generic of a proprietary drug widely prescribed in a particular service. Response.
    Adams J
    N Z Bioeth J; 2003 Oct; 4(3):22-3. PubMed ID: 15597478
    [No Abstract]   [Full Text] [Related]  

  • 26. The pharmaceutical situation in the Philippines.
    Hartigan-Go K
    Aust Health Rev; 2001; 24(2):25-31. PubMed ID: 11496467
    [No Abstract]   [Full Text] [Related]  

  • 27. Insurers, PBMs continue to fight for bigger, better drug price discounts.
    Herman B
    Mod Healthc; 2015 Aug; 45(31):14. PubMed ID: 26540771
    [No Abstract]   [Full Text] [Related]  

  • 28. Reimbursement for drugs under third-party programs.
    Palumbo FB
    Pharm Res; 1990 Jan; 7(1):108-9. PubMed ID: 2405381
    [No Abstract]   [Full Text] [Related]  

  • 29. Is There a Cure for High Drug Prices? A Special Investigation From Consumer Reports Best Buy Drugs.
    Consum Rep; 2016 Aug; 81(8):52-60. PubMed ID: 27459753
    [No Abstract]   [Full Text] [Related]  

  • 30. Competition between brand-name and generics--analysis on pricing of brand-name pharmaceutical.
    Kong Y
    Health Econ; 2009 May; 18(5):591-606. PubMed ID: 18816580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drugs: budget busters or cost cutters in future health care?
    Egger E
    Health Care Strateg Manage; 1999 Mar; 17(3):1, 22-3. PubMed ID: 10351640
    [No Abstract]   [Full Text] [Related]  

  • 32. Forecasting the future.
    Tecnologica; 1999 Dec; ():1, 3-6, 14-5. PubMed ID: 10848110
    [No Abstract]   [Full Text] [Related]  

  • 33. Policy goals: what the elderly can live with.
    Wegner F
    Hosp Formul; 1978 Apr; 13(4):296-7, 300. PubMed ID: 10306920
    [No Abstract]   [Full Text] [Related]  

  • 34. Problematic Jumps in Drug Prices and What You Can Do.
    Shaughnessy AF
    Am Fam Physician; 2017 Jul; 96(1):16-18. PubMed ID: 28671371
    [No Abstract]   [Full Text] [Related]  

  • 35. How companies stall generics and keep themselves healthy.
    Stolberg SG; Gerth J
    N Y Times Web; 2000 Jul; ():A1, A14, A15. PubMed ID: 11785519
    [No Abstract]   [Full Text] [Related]  

  • 36. Financing and Distribution of Pharmaceuticals in the United States.
    Dabora MC; Turaga N; Schulman KA
    JAMA; 2017 Jul; 318(1):21-22. PubMed ID: 28505252
    [No Abstract]   [Full Text] [Related]  

  • 37. Financial consequences of drug benefit plans.
    Motheral B; Sheth J
    JAMA; 2003 Jan 22-29; 289(4):423-4; author reply 424. PubMed ID: 12533119
    [No Abstract]   [Full Text] [Related]  

  • 38. Financial consequences of drug benefit plans.
    Hsu J; Reed M
    JAMA; 2003 Jan 22-29; 289(4):423; author reply 424. PubMed ID: 12533118
    [No Abstract]   [Full Text] [Related]  

  • 39. Financial consequences of drug benefit plans.
    Clark BE; Garis RI
    JAMA; 2003 Jan 22-29; 289(4):423; author reply 424. PubMed ID: 12533117
    [No Abstract]   [Full Text] [Related]  

  • 40. Prescription drug benefits and health status among Medicare patients.
    Moldawsky R
    JAMA; 2003 Oct; 290(15):1994; author reply 1994-5. PubMed ID: 14559949
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.